1-3 of 3
Gang Ye
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Clinical Study of Humanized BCMA-Single-Domain Antibodies-Targeting CAR T (BCMA-CART) in Patients with Relapsed/Refractory Multiple Myeloma

Gaofeng Zheng, Heng Mei, Gang Ye, Ling Zhou, Cheng Wen, Zhuoxiao Cao, Zhen Cai
Journal: Blood
Blood (2023) 142 (Supplement 1): 3489.
https://doi.org/10.1182/blood-2023-186619
Published: 2023
Journal Articles

Allogeneic CAR-NK Cell Therapy Targeting Both BCMA and GPRC5D for the Treatment of Multiple Myeloma

Zhuoxiao Cao, Cuiqing Yang, Yifang Wang, Chao Wang, Qingyang Wang, Gang Ye, Tingting Liu, Qin Wang, Huanyu Wang, Yanxue Gong, Biye Wang, Fuwei Jiang
Journal: Blood
Blood (2022) 140 (Supplement 1): 7378.
https://doi.org/10.1182/blood-2022-159289
Published: 2022
Journal Articles

Study of the Combination of Bortezomib with PPAR/RXR Agonists Rosiglitazone and Bexarotene in Lymphoproliferative Disorder-Derived Cell LinesĪ³.

Ellen Friday, Gang Ye, Francesco Turturro
Journal: Blood
Blood (2005) 106 (11): 4427.
https://doi.org/10.1182/blood.V106.11.4427.4427
Published: 2005